Please select the option that best describes you:
Do you frequently recommend the HPV vaccination series to patients above 26 years old?
What patient factors would make you more likely to recommend? Cost-effectiveness discussion as published in Annals of Internal Medicine:
Answer from: at Community Practice
The FDA approved the use of the 9-valent HPV vaccine in adults aged 27-45 in October 2018. In June 2019, the ACIP recommended that men and women aged 27-45 discuss vaccination with their doctor in a shared decision-making model. Extending mass vaccination for all adults aged 27-45 would cost approxi...
Sign In or Register to read more